Importantly, stimulation of myeloma cells with IL-6 increased the proportion of CD45RO in the raft fractions, where CD45RO formed a complex with IL-6R, gp130, STAT3 and PKC, that could potentiate the activation of STAT3, PKC and downstream NF-κB. The gene discussed is PRRT2; the disease is plasma cell myeloma.